| RS137852623 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Sarcoglycanopathy |
| RS137852624 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS137852625 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS137852626 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS137852627 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS137852628 |
KRT2
|
Health Risk |
Pathogenic |
Ichthyosis bullosa of Siemens, Ichthyosis bullosa of Siemens |
| RS137852629 |
KRT2
|
Health Risk |
Pathogenic |
Ichthyosis bullosa of Siemens, Exfoliative ichthyosis |
| RS137852630 |
KRT2
|
Health Risk |
Pathogenic |
Ichthyosis bullosa of Siemens, Ichthyosis bullosa of Siemens |
| RS137852631 |
KRT2
|
Health Risk |
Pathogenic |
Ichthyosis bullosa of Siemens, Ichthyosis bullosa of Siemens |
| RS137852632 |
KRT2
|
Health Risk |
Pathogenic |
Ichthyosis bullosa of Siemens, Ichthyosis bullosa of Siemens |
| RS137852633 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia, dopa-responsive |
| RS137852634 |
SCNN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism, type IB1 |
| RS137852635 |
SCNN1A
|
Health Risk |
Likely pathogenic |
Pseudohypoaldosteronism, type IB1 |
| RS137852636 |
HMGCS2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS137852637 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, HMGCS2-related disorder |
| RS137852638 |
HMGCS2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS137852639 |
HMGCS2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS137852640 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS137852641 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS137852642 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS137852643 |
GARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2D, Charcot-Marie-Tooth disease type 2 |
| RS137852644 |
GARS1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS137852645 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2D, Charcot-Marie-Tooth disease |
| RS137852646 |
GARS1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS137852647 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2D, Neuronopathy |
| RS137852648 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2D, Charcot-Marie-Tooth disease type 2D |
| RS137852649 |
ACADSB
|
Health Risk |
Pathogenic |
Deficiency of 2-methylbutyryl-CoA dehydrogenase, Deficiency of 2-methylbutyryl-CoA dehydrogenase |
| RS137852650 |
COMP
|
Health Risk |
Pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS137852651 |
COMP
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia type 1, Abnormality of the skeletal system |
| RS137852652 |
COMP
|
Health Risk |
Pathogenic |
Epiphyseal dysplasia, multiple |
| RS137852653 |
COMP
|
Health Risk |
Pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS137852654 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia |
| RS137852655 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudoachondroplasia, severe |
| RS137852656 |
COMP
|
Health Risk |
Pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS137852657 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS137852659 |
FGF8
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 6 with or without anosmia, Hypogonadotropic hypogonadism 6 with or without anosmia |
| RS137852660 |
FGF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 6 with or without anosmia, Hypogonadotropic hypogonadism 6 with or without anosmia |
| RS137852661 |
FGF8
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 6 with or without anosmia, Hypogonadotropic hypogonadism 6 with or without anosmia |
| RS137852662 |
FGF8
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 6 with or without anosmia, Hypogonadotropic hypogonadism 6 with or without anosmia |
| RS137852663 |
FGF8
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 6 with or without anosmia, Hypogonadotropic hypogonadism 6 with or without anosmia |
| RS137852664 |
FGF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 6 with or without anosmia, Holoprosencephaly 1 |
| RS137852665 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS137852666 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2S, Autosomal recessive distal spinal muscular atrophy 1 |
| RS137852667 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS137852668 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS137852669 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS137852670 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Autosomal recessive distal spinal muscular atrophy 1 |
| RS137852671 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS137852672 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS137852673 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Type 2 diabetes mellitus, Diabetes mellitus |
| RS137852674 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Diabetes mellitus |
| RS137852675 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS137852676 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Diabetes mellitus, permanent neonatal 3 |
| RS137852677 |
STAT1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS137852678 |
STAT1
|
Health Risk |
Pathogenic |
Immunodeficiency 31B, Immunodeficiency 31B |
| RS137852679 |
STAT1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS137852680 |
STAT1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency |
| RS137852682 |
CLCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS137852683 |
NKX2-5
|
Health Risk |
Pathogenic |
Atrial septal defect 7, Atrioventricular septal defect |
| RS137852686 |
NKX2-5
|
Health Risk |
Pathogenic |
Atrioventricular septal defect, somatic |
| RS137852687 |
KLF1
|
Health Risk |
Pathogenic |
BLOOD GROUP--LUTHERAN INHIBITOR, BLOOD GROUP--LUTHERAN INHIBITOR |
| RS137852688 |
KLF1
|
Health Risk |
Likely pathogenic |
BLOOD GROUP--LUTHERAN INHIBITOR, BLOOD GROUP--LUTHERAN INHIBITOR |
| RS1378526888 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS137852689 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS137852690 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS137852691 |
OPCML
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS137852692 |
NKX2-1
|
Health Risk |
Pathogenic |
Brain-lung-thyroid syndrome, Brain-lung-thyroid syndrome |
| RS137852693 |
NKX2-1
|
Health Risk |
Pathogenic/Likely pathogenic |
Brain-lung-thyroid syndrome, Inborn genetic diseases |
| RS137852694 |
NKX2-1
|
Health Risk |
Pathogenic |
Benign hereditary chorea, Benign hereditary chorea |
| RS137852695 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Inborn genetic diseases |
| RS137852696 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Retinitis pigmentosa |
| RS137852697 |
PPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS137852698 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS137852699 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Inborn genetic diseases |
| RS137852700 |
PPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal Ceroid-Lipofuscinosis |
| RS137852701 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS137852702 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS137852704 |
SCNN1B
|
Health Risk |
Pathogenic |
Liddle syndrome 1, Bronchiectasis with or without elevated sweat chloride 1 |
| RS137852707 |
SCNN1B
|
Health Risk |
Pathogenic |
Liddle syndrome 1, Liddle syndrome 1 |
| RS137852708 |
SCNN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Liddle syndrome 1, Bronchiectasis with or without elevated sweat chloride 1 |
| RS137852709 |
SCNN1B
|
Health Risk |
Likely pathogenic |
Bronchiectasis with or without elevated sweat chloride 1, Pseudohypoaldosteronism |
| RS137852710 |
SCNN1B
|
Health Risk |
Pathogenic |
Bronchiectasis with or without elevated sweat chloride 1, Bronchiectasis with or without elevated sweat chloride 1 |
| RS137852714 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS137852715 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852716 |
EHMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852717 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852718 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852720 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS137852721 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852722 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852724 |
EHMT1
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852725 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852726 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852727 |
EHMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS137852728 |
CEBPA
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS137852734 |
WNK1
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS137852735 |
WNK1
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS137852736 |
RETREG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Neuropathy |
| RS137852737 |
RETREG1
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS137852738 |
RETREG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Neuropathy |